Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Aspartic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.56 |
| ▸ | GRIK1 | P39086 | 10/20 | 0.54 |
| ▸ | GRIK2 | Q13002 | 6/20 | 0.54 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.52 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.52 |
| ▸ | SLC1A3 | P43003 | 5/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 5/20 | 0.50 |
| ▸ | GRIA4 | P48058 | 4/20 | 0.50 |
| ▸ | GRIK3 | Q13003 | 4/20 | 0.50 |
| ▸ | GRIK5 | Q16478 | 4/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.50 |
| ▸ | GRIA2 | P42262 | 3/20 | 0.50 |
| ▸ | GRIA1 | P42261 | 2/20 | 0.50 |
| ▸ | GRM8 | O00222 | 1/20 | 0.50 |
| ▸ | GRM6 | O15303 | 1/20 | 0.50 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.50 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.50 |
| ▸ | GSR | P00390 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | GRM5 | P41594 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aspartic Acid SCHEMBL7204819 | 1.00 | SLC7A5 (0.56) | SLC7A5GRIK1GRIK2GRM1GRM2 | |
| Aspartic Acid SCHEMBL8383423 | 0.94 | SLC7A5 (0.56) | SLC7A5GRIK1GRIK2GRM1GRM2 | |
| Aspartic Acid SCHEMBL28054217 | 0.94 | SLC7A5 (0.56) | SLC7A5GRIK1GRIK2GRM1GRM2 | |
| Aspartic Acid SCHEMBL3231 | 0.94 | — | — | |
| D-Aspartate SCHEMBL145539 | 0.94 | — | — | |
| Aspartic Acid SCHEMBL11065189 | 0.94 | GRIK1 (0.56) | SLC7A5GRIK1GRIK2GRM1GRM2 | |
| Aspartic Acid SCHEMBL1526976 | 0.94 | GRIK1 (0.56) | SLC7A5GRIK1GRIK2GRM1GRM2 | |
| Aspartic Acid SCHEMBL3230 | 0.94 | — | — | |
| Aspartic Acid SCHEMBL996424 | 0.94 | GRIK1 (0.56) | SLC7A5GRIK1GRIK2GRM1GRM2 | |
| Aspartic Acid SCHEMBL11065185 | 0.94 | GRIK1 (0.56) | SLC7A5GRIK1GRIK2GRM1GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0734252-B1 | VINCA-ALKALOID VESICLES WITH ENHANCED EFFICACY AND TUMOR TARGETING PROPERTIES | NEXSTAR PHARMACEUTICALS INC (US) | 2003-04-16 | — | — | EP | disclosed |
| US-6120800-A | TO CONTROL DELIVERY OF ENCAPSULATED ANTICANCER AGENTS TO TUMORS IN MAMMALS; DECREASED TOXICITY | NEXSTAR PHARMACEUTICALS, INC. (US) | 2000-09-19 | — | — | US | disclosed |
| US-5888537-A | LIPOSOMES COMPRISED OF PHOSPHATIDYL CHOLINE, CHOLESTEROL AND PHOSPHATIDYL GLYCEROL, HAVING INTERNAL AQUEOUS PHASE CONTAINING CATIONIC VINCA ALKALOID AND ANION OF LOW MEMBRANE PERMEABILITY | NEXSTAR PHARMACEUTICALS, INC. (US) | 1999-03-30 | — | — | US | disclosed |
| US-5714163-A | COMPRISING DISTEAROYLPHOSPHATIDYL CHOLINE, CHOLESTEROL AND DISTEAROYLPHOSPHATIDYL GLYCEROL | NEXSTAR PHARMACEUTICALS, INC. (US) | 1998-02-03 | — | — | US | disclosed |
| EP-0734252-A1 | VINCA-ALKALOID VESICLES WITH ENHANCED EFFICACY AND TUMOR TARGETING PROPERTIES | NeXstar Pharmaceuticals, Inc. (US) | 1996-10-02 | — | — | EP | disclosed |
| WO-1996000057-A1 | VINCA-ALKALOID VESICLES WITH ENHANCED EFFICACY AND TUMOR TARGETING PROPERTIES | VESTAR, INC. (US) | 1996-01-04 | — | — | WO | disclosed |